Lawrence Blume is lead advisor for food science and biotechnology innovation. As an Innovation Advisor, he works closely with life science, food & beverage and consumer goods companies to develop external insights, business models, and technical unlocks that yield disruptive innovation in core products and/or new and emerging products/markets. Dr. Blume brings expertise in leading technology-focused opportunity forecasts in support of competitive advantage, product differentiation, and commercialization strategies for C-level executives at companies ranging from early startups to Fortune 500's.
Over the last decade, Dr. Blume has continued to apply his knowledge of cannabinoid neuropharmacology towards novel commercial applications, including F&B new product development. Prior to RTI, Lawrence worked in academic technology transfer and early-stage life science investment funding to support commercialization and growth of emerging technologies and companies.